Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT05568888
Other study ID # BE1116_3006
Secondary ID 2021-005060-21
Status Recruiting
Phase Phase 3
First received
Last updated
Start date March 28, 2023
Est. completion date September 2026

Study information

Verified date June 2024
Source CSL Behring
Contact Trial Registration Coordinator
Phone +1 610-878-4000
Email clinicaltrials@cslbehring.com
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This is a prospective, multicenter, randomized, double-blind, placebo-controlled, parallel-group, large simple trial to investigate the efficacy and safety of a single intravenous (IV) infusion of BE1116 in subjects who have traumatic injury, with confirmed or suspected acute major bleeding and / or predicted to receive a large volume blood product transfusion.


Recruitment information / eligibility

Status Recruiting
Enrollment 8000
Est. completion date September 2026
Est. primary completion date September 2026
Accepts healthy volunteers No
Gender All
Age group 15 Years and older
Eligibility Inclusion Criteria: - (a) Estimated age = 15 years. Older minimum age is required in some locations. FOR United Kingdom: Estimated or actual age = 16 years FOR Australia: Estimated or actual age = 18 years AND (b) Estimated or actual weight = 50 kg (110 lbs). - Traumatic injury with confirmed or suspected acute major bleeding and/or Revised Assessment of Bleeding and Transfusion (RABT) score = 2 - Activation of massive transfusion protocol Exclusion Criteria: - Healthcare professional cardiopulmonary resuscitation including chest compressions for = 5 consecutive minutes at any time before randomization - Isolated penetrating or blunt cranial injury, or exposed brain matter - Isolated burns estimated to be > 20% total body surface area or suspected inhalational injury - Known anticoagulation treatment or a history of a TEE, within the past 3 months.

Study Design


Related Conditions & MeSH terms


Intervention

Drug:
BE1116
4-Factor Prothrombin Complex administered by intravenous (IV) infusion
Placebo
Administered by IV infusion

Locations

Country Name City State
Australia Royal Adelaide Adelaide South Australia
Australia Royal Hobart Hospital Hobart Tasmania
Australia St. George Hospital Kogarah Sydney
Australia Alfred Hospital Melbourne Victoria
Australia Royal Perth Hospital Perth Western Australia
Australia John Hunter Hospital Sydney New Lambton
Australia Liverpool Hospital Sydney Liverpool
Australia Royal Prince Alfred Hospital Sydney New South Wales
Australia Westmead Hospital Westmead Sydney
United Kingdom Queen Elizabeth Hospital Birmingham
United Kingdom Southmead Hospital Bristol
United Kingdom Cambridge Addenbrookes University Cambridge
United Kingdom University Hospital Coventry Coventry
United Kingdom Hull Royal Infirmary Hull University Teaching Hospitals NHS Trust Hull
United Kingdom Leeds Teaching Hospital Leeds
United Kingdom Aintree University Hospital Liverpool
United Kingdom Imperial College Healthcare London
United Kingdom St. Georges Hospital London
United Kingdom Royal Victoria Infirmary Newcastle Upon Tyne
United Kingdom Queen's Medical Centre, Nottingham University Hospitals NHS Trust Nottingham
United Kingdom John Radcliffe Hospital Oxford
United Kingdom Sheffield Teaching Hospital Sheffield
United Kingdom Royal Stoke University Hospital Stoke-on-Trent
United States Summa Health System - Akron Campus Akron Ohio
United States University Hospital Ann Arbor Michigan
United States Grady Memorial Hospital Atlanta Georgia
United States Augusta University Medical Center Augusta Georgia
United States University of Colorado Aurora Aurora Colorado
United States Dell Seton Medical Center Austin Texas
United States UAB Hospital Birmingham Alabama
United States Tufts Medical Center Boston Massachusetts
United States Erie County Medical Center Buffalo New York
United States Cooper Health Care Camden New Jersey
United States Chandler Regional Medical Center Chandler Arizona
United States Carolinas Medical Center Charlotte North Carolina
United States Erlanger Baroness Hospital Chattanooga Tennessee
United States University of Chicago Medical Center Chicago Illinois
United States University of Cincinnati Medical Center Cincinnati Ohio
United States MetroHealth Medical Center Cleveland Ohio
United States UC Health Memorial Hospital Central Colorado Springs Colorado
United States The Ohio State University Columbus Ohio
United States Denver Health and Hospital Authority Denver Colorado
United States Henry Ford Hospital Detroit Michigan
United States Duke University Durham North Carolina
United States University Medical Center El Paso El Paso Texas
United States Sanford Medical Center Fargo Fargo North Dakota
United States Brooke Army Medical Center Fort Sam Houston Texas
United States JPS Health Network (John Peter Smith Hospital) Fort Worth Texas
United States Northeast Georgia Health System Gainesville Georgia
United States Penn State Milton S. Hershey Medical Center Hershey Pennsylvania
United States Ben Taub General Hospital - Baylor Medical Center - Harris Health Network Houston Texas
United States Memorial Hermann Hospital Houston Texas
United States Indiana University Methodist Hospital Indianapolis Indiana
United States St. Vincent's Hospital Indianapolis Indiana
United States University of Iowa Hospitals and Clinics Iowa City Iowa
United States University of Mississippi Medical Center (UMMC) Jackson Mississippi
United States UF Health Jacksonville Jacksonville Florida
United States Kansas University Medical Center Kansas City Kansas
United States University of Tennessee Medical Center - UTMCK Knoxville Tennessee
United States University of Kentucky Albert B. Chandler Hospital Lexington Kentucky
United States UAMS Medical Center Little Rock Arkansas
United States LAC+USC Medical Center Los Angeles California
United States Ronald Reagan UCLA Medical Center Los Angeles California
United States University of Louisville Hospital Louisville Kentucky
United States Medical Center of the Rockies Loveland Colorado
United States Atrium Health - Medical Center of central Georgia Macon Georgia
United States University Hospital Madison Wisconsin
United States Regional Medical Center Memphis Tennessee
United States University of Miami/Ryder Trauma Center Miami Florida
United States Froedtert Memorial Lutheran Hospital Milwaukee Wisconsin
United States NYU Langone Mineola New York
United States Hennepin County Medical Center Minneapolis Minnesota
United States University of South Alabama Mobile Alabama
United States Riverside University Health System Medical Center Moreno Valley California
United States J.W. Ruby Memorial Hospital Morgantown West Virginia
United States Intermountain Medical Center Murray Utah
United States Vanderbilt Hospital and Clinics Nashville Tennessee
United States Yale New Haven Hospital New Haven Connecticut
United States University Medical Center of New Orleans New Orleans Louisiana
United States Rutgers New Jersey Medical School Newark New Jersey
United States University of Oklahoma Health Science Center Oklahoma City Oklahoma
United States UNMC (University of Nebraska Medical Center) Omaha Nebraska
United States UC Irvine Orange California
United States Penn Presbyterian Medical Center Philadelphia Pennsylvania
United States Temple University Hospital Philadelphia Pennsylvania
United States Banner - University Medical Center Phoenix Phoenix Arizona
United States St. Joseph's Hospital and Medical Center Phoenix Arizona
United States Valleywise Medical Center Phoenix Arizona
United States University of Pittsburgh Medical Center Presbyterian Pittsburgh Pennsylvania
United States Oregon Health and Sciences University Hospital Portland Oregon
United States Brown University (Rhode Island Hospital) Providence Rhode Island
United States Jamaica Hospital Medical Center Richmond Hill New York
United States North Memorial Hospital Robbinsdale Minnesota
United States UC Davis Medical Center Sacramento California
United States Barnes Jewish Hospital Saint Louis Missouri
United States SSM Health St. Louis Saint Louis Missouri
United States Health Partners Regions Hospital Saint Paul Minnesota
United States University of Utah Hospital Salt Lake City Utah
United States University Hospital San Antonio Texas
United States UC San Diego Medical Center San Diego California
United States San Francisco General Hospital and Trauma Center San Francisco California
United States HonorHealth Scottsdale Osborn Medical Center Scottsdale Arizona
United States Harborview Medical Center Seattle Washington
United States LSU Health Shreveport Shreveport Louisiana
United States Sanford USD Medical Center Sioux Falls South Dakota
United States Mercy Health - St. Vincent Medical Center Toledo Ohio
United States Capital Health Regional Medical Center Trenton New Jersey
United States University Medical Center Tucson Tucson Arizona
United States UT Health Tyler Tyler Texas
United States George Washington University Hospital Washington District of Columbia
United States MedStar Washington Medical Center Washington District of Columbia
United States Reading Hospital West Reading Pennsylvania
United States Wake Forest Medical Center Winston-Salem North Carolina

Sponsors (1)

Lead Sponsor Collaborator
CSL Behring

Countries where clinical trial is conducted

United States,  Australia,  United Kingdom, 

Outcome

Type Measure Description Time frame Safety issue
Primary Difference in proportion of subjects in all-cause mortality in the BE1116 arm compared with the placebo arm Up to 6 hours after randomization
Secondary Difference in proportion of subjects in all-cause in-hospital mortality in the BE1116 arm compared with the placebo arm In-hospital mortality will only be recorded and assessed for the primary hospitalization. Up to 24 hours after randomization
Secondary Difference in proportion of subjects in all-cause in-hospital mortality in the BE1116 arm compared with the placebo arm In-hospital mortality will only be recorded and assessed for the primary hospitalization. Up to 30 days after randomization
Secondary Difference in proportion of subjects who undergo surgical or interventional radiological procedures to stop bleeding related to the primary injury in the BE1116 arm compared with the placebo arm Up to 24 hours after randomization
Secondary Number and proportion of subjects with serious adverse events (SAEs) considered related to BE1116 or placebo Up to 30 days after randomization
Secondary Number and proportion of in-hospital overall and related Thromboembolic events (TEEs) to BE1116 or placebo Thromboembolic events (TEEs), symptomatic or asymptomatic, and arterial or venous (eg, deep vein thrombosis, pulmonary embolism, ischemic stroke [including thromboembolic stroke], myocardial infarction). Superficial thromboses will not be included as adverse events of special interest. Up to 30 days after randomization
Secondary Number and proportion of subjects with Acute respiratory distress syndrome (ARDS) to BE1116 or placebo Up to 30 days after randomization
Secondary Number and proportion of subjects with Multiple organ failure to BE1116 or placebo Up to 30 days after randomization
Secondary Number and proportion of subjects with Acute kidney injury (AKI) requiring renal replacement therapy (dialysis, hemofiltration, or hemodiafiltration) to BE1116 or placebo Up to 30 days after randomization
See also
  Status Clinical Trial Phase
Recruiting NCT04992130 - Sport Concussion Performance-Based Prevention Program N/A
Recruiting NCT05451394 - Prevention of Injury in Military Settings Through the Use of Body Awareness. N/A
Withdrawn NCT03928015 - Evaluation of Dronabinol For Acute Pain Following Traumatic Injury Phase 2
Recruiting NCT04588311 - ErythroPOietin Alfa to Prevent Mortality and Reduce Severe Disability in Critically Ill TRAUMA Patients Phase 3
Recruiting NCT05437575 - Prehospital Analgesia INtervention Trial (PAIN) Phase 3
Recruiting NCT06034834 - Near-Infrared Imaging for Perfusion Assessment of Traumatic Soft Tissue and Skeletal Injuries N/A
Completed NCT02412982 - Evaluation of Venous Thromboembolism Prevention in High-Risk Trauma Patients Phase 4
Withdrawn NCT01497678 - Musculotendinous Tissue Unit Repair and Reinforcement (MTURR) Coordinating Center N/A
Completed NCT05225441 - National Investigation in College and High School Among Adolescents on Health and Substances at the FSEF
Completed NCT03927729 - Use of Methoxyflurane (Penthrox) as an Antalgic in Hospital Trauma N/A
Not yet recruiting NCT06366282 - Pediatric and Caregiver Traumatic Stress Intervention (PACTS) N/A
Not yet recruiting NCT06383650 - Use of 81 vs 325mg of ASA in Treatment of BCVI Early Phase 1
Completed NCT04778332 - Trottinettes Urgences 2019-2020
Recruiting NCT06404177 - Enantyum® IV Versus Piroxen® IM in Emergency Pain Management Phase 3
Recruiting NCT05086757 - Evaluation of Trauma Center-Based Intervention for Adolescent Traumatic Injury Survivors N/A
Completed NCT03628846 - Opioid Use After Traumatic Injury in Adolescents
Active, not recruiting NCT05320445 - A Psychosocial Transitional Group to Improve Adaptation, Coping and Mental Health Outcomes Following Trauma N/A
Completed NCT01771055 - Direct Peritoneal Resuscitation Effects in the Damage Control Patient N/A
Completed NCT01485419 - Characterization of the Early Sex Hormone Milieu Post Injury and Relationship With Resuscitation Requirements and Coagulopathy N/A
Completed NCT04980937 - Peroneal Nerve Injury: a 20- Year Retrospective Case Series Study